A High Through-put Platform for Recombinant Antibodies to Folded Proteins

Antibodies are key reagents in biology and medicine, but commercial sources are rarely recombinant and thus do not provide a permanent and renewable resource. Here, we describe an industrialized platform to generate antigens and validated recombinant antibodies for 346 transcription factors (TFs) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hornsby, Michael, Paduch, Marcin, Miersch, Shane, Sääf, Annika, Matsuguchi, Tet, Lee, Brian, Wypisniak, Karolina, Doak, Allison, King, Daniel, Usatyuk, Svitlana, Perry, Kimberly, Lu, Vince, Thomas, William, Luke, Judy, Goodman, Jay, Hoey, Robert J., Lai, Darson, Griffin, Carly, Li, Zhijian, Vizeacoumar, Franco J., Dong, Debbie, Campbell, Elliot, Anderson, Stephen, Zhong, Nan, Gräslund, Susanne, Koide, Shohei, Moffat, Jason, Sidhu, Sachdev, Kossiakoff, Anthony, Wells, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2015
Materias:
Technological Innovations and Resources
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597156/
https://www.ncbi.nlm.nih.gov/pubmed/26290498
http://dx.doi.org/10.1074/mcp.O115.052209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597156/
https://www.ncbi.nlm.nih.gov/pubmed/26290498
http://dx.doi.org/10.1074/mcp.O115.052209

Ejemplares similares